Glia as a Turning Point in the Therapeutic Strategy of Parkinsons Disease

E-ISSN： 1996-3181|9|3|349-372

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.9, Iss.3, 2010-07, pp. : 349-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Therapeutic Strategy for Parkinson's and Alzheimer's Disease

Current Medicinal Chemistry, Vol. 17, Iss. 25, 2010-09 ,pp. : 2764-2774

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4936-4947

Bentham Science Publishers

Access to resources Recommend Favorite

Blocking Receptor Protein Tyrosine Phosphatase &bgr; /&zgr;: A Potential Therapeutic Strategy for Parkinson's Disease

Current Medicinal Chemistry, Vol. 16, Iss. 25, 2009-09 ,pp. : 3322-3329

Bentham Science Publishers

Access to resources Recommend Favorite

Neurotrophic Factors as a Protective Strategy in Parkinson's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 754-763

Bentham Science Publishers

Access to resources Recommend Favorite

Iron Chelators as Potential Therapeutic Agents for Parkinson's Disease

Current Bioactive Compounds, Vol. 4, Iss. 3, 2008-10 ,pp. : 150-158

Bentham Science Publishers

Access to resources Recommend Favorite